Salivary concentrations of atrazine reflect free atrazine plasma levels in rats

Journal of Toxicology and Environmental Health - Part A

Volumn 53, Issue 4, 1998, Pages 283-292

  Lu, Chensheng ^a   Anderson, Leigh C ^b   Morgan, Michael S ^a   Fenske, Richard A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL BLOOD; ARTICLE; BIOLOGICAL MONITORING; BLOOD LEVEL; BLOOD SAMPLING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SALIVA LEVEL; ULTRAFILTRATION;

ANIMALS; ATRAZINE; BIOLOGICAL MARKERS; ENVIRONMENTAL EXPOSURE; HERBICIDES; MALE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; SALIVA;

ANIMALIA;

EID: 0032549071     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/009841098159286     Document Type: Article

References (27)

1. Bertilsson, L., Braithwaite, R., Tybring, G., Garle, M. and Borga, O. 1979. Techniques for plasma protein binding of demethylchlorimipramine. Clin. Pharmacol. Ther. 26:265-271.
2. Brors, O., Sager, G., Sandnes, D. and Jacobsen, S. 1983. Binding of theophylline in human serum determined by ultrafiltration and equilibrium dialysis. Br. J. Clin. Pharmacol. 3:243-249.
3. Cordonnier, J., Van den Heede, M. and Heyndrickx, A. 1987. Saliva concentrations of disopyramide cannot substitute the drug's plasma concentrations. J. Anal. Toxicol. 11:179-181.
4. Dawes, C. P., Kandell, M. J. and John, V. A. 1978. Comparison of plasma and saliva levels of metoprolol and oxprenolol. Br. J. Clin. Pharmacol. 5:217-221.
5. Derendorf, H. P., Rohdewald, H., Mollmann, H., Rehder, J., Barth, J. and Neveling, D. 1985. Pharmacokinetics of prednisolone after high dose of prednisolone hemisuccinate. Biopharm. Drug Dispos. 6:423-432.
6. DiGregorio, G. J., Piraino, A. J. and Ruch, E. 1978. Diazepam concentrations in parotid saliva, mixed saliva, and plasma. Clin. Pharmacol. Ther. 24:720-725.
7. Gao, Y., Pons, G., Rey, E., Richard, M. O., d'Athis, P., Bertin, L., Thiroux, G., de Blic, J., Scheinmann, P. and Olive, G. 1992. Could saliva stand for plasma in theophylline monitoring in asthmatic children? Still a controversial problem. Fundam. Clin. Pharmacol. 6:191-196.
8. Haeckel, R. 1993. Factors influencing the saliva/plasma ratio of drugs. Ann. NY Acad. Sci. 694:128142.
9. Haeckel, R. and Hanecke, P. 1993. The application of saliva, sweat and tear fluid for diagnostic purposes. Ann. Biol. Clin. 50:903-910.
10. Hayashi, Y., Watanabe, J. and Ozeki, S. 1989. Salivary excretion of 5-fluorouracil (5-FU). IV. Dependency of saliva/plasma concentration ratio and salivary clearance on plasma concentration of 5-FU during constant rate infusion in rats. J. Pharmacobiodyn. 12:137-144.
11. Jung, D., Mayersohn, M. and Perrier, D. 1981. The "ultra-free" ultrafiltration technique compare with equilibrium dialysis for determination of unbound thiopental concentrations in serum. Clin. Chem. 27:166-168.
12. Jusko, W. J., Gerbracht, L., Golden, L. H. and Koup, J. R. 1975. Digoxin concentrations in serum and saliva. Res. Commun. Chem. Pathol. Pharmacol. 10:189-192.
13. Lu, C, Anderson, L. C. and Fenske, R. A. 1997a. Determination of atrazine levels in whole saliva and plasma in rats: Potential of salivary monitoring for occupational exposure. J. Toxicol. Environ. Health 50:101-111.
14. Lu, C, Anderson, L. C., Morgan, M. S. and Fenske, R. A. 1997b. Correspondence of salivary and plasma concentrations of atrazine in rats under variable salivary flow rate and plasma concentration. J. Toxicol. Environ. Health 52:317-329.
15. Matin, S. B., Wan, S. H. and Karam, J. H. 1974. Pharmacokinetics of tolbutamide; Prediction by concentrations in saliva. Clin. Pharmacol. Ther. 16:1052-1058.
16. Nagasako, S., Hayashibara, M., Katagiri, Y. and Iwamoto, K. 1992. Salivary excretion of mexlletlne after bolus intravenous administration in rats. J. Pharm. Pharmacol. 44:55-57.
17. Nagasako, S., Iwamoto, K., Hayashibara, M. and Katagiri, Y. 1993. Dependency of salivary excretion of mexiletine on the plasma concentration in rat. J. Pharm. Pharmacol. 45:154-156.
18. Nigg, H. N. and Wade, S. E. 1992. Saliva as a monitoring medium for chemicals. Rev. Environ. Contam. Toxicol. 129:95-119.
19. Pacifici, G. M. and Viani, A. 1992. Methods of determining plasma and tissue binding of drugs. Clin. Pharmacol. 23:449-468.
20. Paxton, J. W. 1979. Measurement of drugs in saliva: A review. Methods Find. Exp. Clin. Pharmacol. 1:11-21.
21. Rasmussen, F. 1964. Salivary excretion of sulphonamides and barbiturates by cows and goats. Acta Pharmacol. Toxicol. 21:11-19.
22. Ritchel, W. A. and Thompson, G. A. 1983. Monitoring of drug concentrations in saliva: A non-invasive pharmacokinetic procedure. Methods Find. Exp. Clin. Pharmacol. 5:511-525.
23. Siegel, I. A. 1987. Use of saliva to monitor drug concentrations. In The salivary system, ed. L. M. Sreebny, pp. 157-178. Boca Raton, FL: CRC Press.
24. Vesell, E. S., Passananti, T., Glenwright, P. A. and Dvochik, B. H. 1975. Studies on the disposition of antipyrine, aminopyrine and phenacetin using plasma, saliva and urine. Clin. Pharmacol. Ther. 18:259-272.
25. Vining, R. F., McGinley, R. A., Maksvytis, J. J. and Ho, K. Y. 1983. Salivary cortisol: A better measure of adrenal cortical function than serum cortisol. Ann. Clin. Biol. Chem. 20:329-335.
26. Watson, I. D. and Stewart, M. J. 1986. Trimethoprim: Prediction of serum concentrations from saliva measurement. Eur. J. Clin. Pharmacol. 30:457-461.
27. Wright, J. D., Boudinot, F. D. and Ujhelyi, M. R. 1996. Measurement and analysis of unbound drug concentrations. Clin. Pharmacokinet. 30:445-462.